Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Urologic Oncology|October 11, 2023
HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) studyG H Ghelani, M Bou Zerdan, J Jacob, et al.
Clinical Genitourinary Cancer|June 6, 2016
Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial CarcinomaG Sonpavde, G R Pond, G Di Lorenzo, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomesP Giannatempo, T Greco, L Mariani, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
British Journal of Cancer|November 16, 2013
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracyA Necchi, M Pennati, N Zaffaroni, et al.
Clinical Genitourinary Cancer|July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial designG R Pond, J Bellmunt, J E Rosenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2025
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trialT Powles, S Tagawa, C Vulsteke, et al.
ESMO Open|June 11, 2025
Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape studyH R Robinson, S Lakritz, D C Pavlick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II studyA Necchi, L Mariani, M Di Nicola, et al.
Pageof 4